Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ·Healthcare·Biotechnology
$5.59
+4.20%
Mkt Cap $435.81M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $1.51M | — | — | -$0.49 | -$0.57 | -16.33% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.46 | -$0.53 | -15.22% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.46 | -$0.44 | +4.35% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$0.56 | -$0.40 | +28.57% | — | — |
| Q1 2025 Mar 6, 2025 | — | — | — | -$0.35 | -$0.40 | -14.29% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.49 | -$0.37 | +24.49% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$0.76 | -$0.48 | +36.84% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.61 | -$0.75 | -22.95% | — | — |
| Q1 2024 Feb 28, 2024 | — | — | — | -$0.50 | -$0.47 | +6.00% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$0.48 | -$0.40 | +16.67% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.47 | -$0.34 | +27.66% | — | — |
| Q2 2023 May 8, 2023 | — | — | — | -$0.48 | -$0.43 | +10.42% | — | — |
| Q1 2023 Feb 28, 2023 | — | — | — | -$0.45 | -$0.41 | +8.89% | — | — |
| Q4 2022 Nov 7, 2022 | — | — | — | -$0.44 | -$0.10 | +77.27% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.52 | -$0.38 | +26.92% | — | — |
| Q2 2022 May 10, 2022 | $3.33M | — | — | -$0.58 | -$0.51 | +12.07% | — | — |
| Q1 2022 Feb 28, 2022 | $85.73M | $192.18M | +124.18% | $0.17 | $1.34 | +688.24% | — | — |
| Q4 2021 Nov 11, 2021 | $141.74M | $32.81M | -76.85% | -$0.05 | -$0.34 | -580.00% | — | — |
| Q3 2021 Aug 12, 2021 | $60.39M | $60.39M | +0.00% | $0.01 | $0.02 | +300.00% | — | — |
| Q2 2021 May 13, 2021 | $522.60M | $65.98M | -87.37% | -$0.05 | $0.34 | +780.00% | — | — |